RSLS - ReShape Lifesciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $246310.24. This is a potential upside of $246305.63 (5342855.31%) from yesterday's end of day stock price of $4.61.

ReShape Lifesciences's activity chart (see below) currently has 2 price targets and 11 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 1.25 days.

Most recent stock forecast was given by BEN HAYNOR from ALLIANCE GLOBAL PARTNERS on 26-May-2022. First documented stock forecast 31-Oct-2016.

Best performing analysts who are covering RSLS - ReShape Lifesciences:

Ben Haynor Kyle Rose Rick Wise Anthony Vendetti

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

2 years 6 months 22 days ago
(26-May-2022)

1/2 (50%)

$17719 (103.74%)

5

Buy

$400

2 years 8 months 19 days ago
(29-Mar-2022)

0/1 (0%)

$243.5 (155.59%)

Hold

5 years 6 months 26 days ago
(22-May-2019)

0/2 (0%)

$900210 (101.74%)

Buy

5 years 9 months 23 days ago
(25-Feb-2019)

0/2 (0%)

$67050 (27.04%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RSLS (ReShape Lifesciences) average time for price targets to be met?

On average it took 1.25 days on average for the stock forecasts to be realized with a an average price target met ratio 12.5

Which analyst has the current highest performing score on RSLS (ReShape Lifesciences) with a proven track record?

BEN HAYNOR

Which analyst has the current lower performing score on RSLS (ReShape Lifesciences) with a proven track record?

ANTHONY VENDETTI

Which analyst has the most public recommendations on RSLS (ReShape Lifesciences)?

Ben Haynor works at LAKE STREET and has 13 price targets and 7 ratings on RSLS

Which analyst is the currently most bullish on RSLS (ReShape Lifesciences)?

Anthony Vendetti with highest potential upside - $0

Which analyst is the currently most reserved on RSLS (ReShape Lifesciences)?

Ben Haynor with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?